BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14963764)

  • 1. Adenotonsillar hypertrophy and post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
    Köpf S; Tönshoff B
    Pediatr Nephrol; 2004 Apr; 19(4):471-2. PubMed ID: 14963764
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
    Shapiro NL; Strocker AM
    Laryngoscope; 2001 Jun; 111(6):997-1001. PubMed ID: 11404611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenotonsillar enlargement in pediatric patients following solid organ transplantation.
    Huang RY; Shapiro NL
    Arch Otolaryngol Head Neck Surg; 2000 Feb; 126(2):159-64. PubMed ID: 10680866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The validity of the OSA-18 among three groups of pediatric patients.
    Strocker AM; Carrer A; Shapiro NL
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):241-7. PubMed ID: 15656959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for adenotonsillar hypertrophy in children following solid organ transplantation.
    Shapiro NL; Strocker AM; Bhattacharyya N
    Int J Pediatr Otorhinolaryngol; 2003 Feb; 67(2):151-5. PubMed ID: 12623151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenotonsillar histopathology after organ transplantation.
    Williamson RA; Huang RY; Shapiro NL
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):231-40. PubMed ID: 11555759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenotonsillar enlargement in pediatric organ transplant recipients: a cross-sectional analysis.
    Chiang S; Vu MC; Nguyen M; Strocker A; Horvath S; Shapiro N
    Otolaryngol Head Neck Surg; 2002 Jul; 127(1):109-14. PubMed ID: 12161739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H; Taheri S
    Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenotonsillar pathology in post-transplant patients.
    Roy S; Vivero RJ; Smith LP
    Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):865-8. PubMed ID: 18395271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe obstructive sleep apnoea due to adenotonsillar hypertrophy after liver transplantation.
    Mulla O; Bajaj Y; Knight L
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23213127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients.
    Herrmann BW; Sweet SC; Hayashi RJ; Canter CE; White FV; Lieu JE
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):303-10. PubMed ID: 16125255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences in clinical and histopathologic features between chronic adenotonsillitis and chronic adenotonsillar hypertrophy].
    Kutluhan A; Uğraş S; Kiriş M; Cankaya H; Kiroğlu AF; Yurttaş V
    Kulak Burun Bogaz Ihtis Derg; 2003 Feb; 10(2):61-7. PubMed ID: 12717059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysomnographic findings in children with adenotonsillar hypertrophy.
    Reynolds CF; Stool S; Holzer B; Coble PA; Kupfer DJ
    Trans Pa Acad Ophthalmol Otolaryngol; 1980; 33(2):183-7. PubMed ID: 7445028
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical Marginal Zone Hyperplasia Is a Mimic for Lymphoma in Pediatric Transplant Recipients: Report of Two Patients.
    Caltharp SA; Qayed M; Park SI
    Pediatr Dev Pathol; 2015; 18(5):416-21. PubMed ID: 25955878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidants and antioxidants in tonsillar and adenoidal tissue in chronic adenotonsillitis and adenotonsillar hypertrophy in children.
    Kiroglu AF; Noyan T; Oger M; Kara T
    Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):35-8. PubMed ID: 15961164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric disorders and symptoms severity in patients with adenotonsillar hypertrophy before and after adenotonsillectomy.
    Soylu E; Soylu N; Yıldırım YS; Sakallıoğlu Ö; Polat C; Orhan I
    Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1775-81. PubMed ID: 24011939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive abilities in children with adenotonsillar hypertrophy.
    Kurnatowski P; Putyński L; Lapienis M; Kowalska B
    Int J Pediatr Otorhinolaryngol; 2006 Mar; 70(3):419-24. PubMed ID: 16216342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and emotional disturbances in children with adenotonsillar hypertrophy.
    Kurnatowski P; Putyński L; Łapienis M; Kowalska B
    J Laryngol Otol; 2008 Sep; 122(9):931-5. PubMed ID: 18047762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does drop in T and A's pose new issue of adenotonsillar hypertrophy?
    Check WA
    JAMA; 1982 Mar; 247(9):1229-30. PubMed ID: 7062531
    [No Abstract]   [Full Text] [Related]  

  • 20. Do children with adenotonsillar hypertrophy have lower IGF-1 and ghrelin levels than the normal children?
    Sen TA; Ayçiçek A
    Int J Pediatr Otorhinolaryngol; 2010 Jun; 74(6):665-8. PubMed ID: 20394991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.